Novel Evidence for Chronic Exposure to Endotoxin in Human Nonalcoholic Steatohepatitis
Froukje J. Verdam +4 more
openalex +2 more sources
Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis.
Abdel-Samiee M +4 more
europepmc +1 more source
Exploring the mechanisms of tetrahydrocurcumin in ameliorating nonalcoholic steatohepatitis based on network pharmacology and gut microbiota analysis <i>in vivo</i> and <i>in vitro</i>. [PDF]
Chen K +9 more
europepmc +1 more source
Serologic Biomarkers for Hepatic Fibrosis in Obese Children with Nonalcoholic Steatohepatitis. [PDF]
Joo JY, Yoo IH, Yang HR.
europepmc +1 more source
Identification of FDFT1 and PGRMC1 as New Biomarkers in Nonalcoholic Steatohepatitis (NASH)-Related Hepatocellular Carcinoma by Deep Learning. [PDF]
Liu Q +9 more
europepmc +1 more source
CAT and CXCL8 are crucial cofactors for the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma, the immune infiltration and prognosis of hepatocellular carcinoma. [PDF]
Yang L +7 more
europepmc +1 more source
Erratum: Lipocalin-2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high-fat diet-fed Ob/Ob mice. [PDF]
Kim KE +12 more
europepmc +1 more source

